Atlas Trials

Comparing Bioavailability When Makena® is Administered in Healthy Post-menopausal Women

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Comparing Bioavailability When Makena® is Administered in Healthy Post-menopausal Women

RecordFirmDate
Comparing Bioavailability When Preservative-free Makena® (Hydroxyprogesterone Caproate Injection, 250 mg/mL) is Administered as an Intramuscular Manual Injection or as a Subcutaneous Injection Using an Auto-injector in Healthy Post-menopausal Women (NCT02940522)AMAG Pharmaceuticals, Inc.2016-09-01

Track Comparing Bioavailability When Makena® is Administered in Healthy Post-menopausal Women automatically

Every clearance here is in the API, with alerts when new ones post.